Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

ARKMEDIC ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   0.6% 0.7% 0.9% 0.6% 0.7% 0.7% 7.5% 7.4%   Credit score (0-100)   97 96 90 97 95 92 32 33   Credit rating   AA AA A AA AA AA BB BBB   Credit limit (kDKK)   1,567.5 1,629.5 1,360.2 2,412.1 2,506.6 2,388.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,836 2,128 1,832 4,640 3,665 2,554 0.0 0.0   EBITDA   1,802 1,030 618 3,335 2,145 1,006 0.0 0.0   EBIT   1,802 1,030 618 3,335 2,145 1,006 0.0 0.0   Pre-tax profit (PTP)   2,551.9 1,570.7 1,102.0 6,537.5 4,800.6 992.1 0.0 0.0   Net earnings   2,051.0 1,279.5 812.5 5,388.3 4,218.8 863.0 0.0 0.0   Pre-tax profit without non-rec. items   2,552 1,571 1,102 6,537 4,801 992 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   15,176 16,456 17,268 22,657 24,875 25,738 21,572 21,572   Interest-bearing liabilities   2,797 3,833 4,999 4,514 2,436 4,281 0.0 0.0   Balance sheet total (assets)   19,485 21,603 25,292 29,596 29,739 31,073 21,572 21,572   Net Debt   2,797 3,833 4,999 4,514 1,499 4,281 -21,572 -21,572     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,836 2,128 1,832 4,640 3,665 2,554 0.0 0.0   Gross profit growth   -53.9% -25.0% -13.9% 153.3% -21.0% -30.3% -100.0% 0.0%   Employees   4 2 3 3 3 3 0 0   Employee growth %   0.0% -50.0% 50.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   19,485 21,603 25,292 29,596 29,739 31,073 21,572 21,572   Balance sheet change%   14.6% 10.9% 17.1% 17.0% 0.5% 4.5% -30.6% 0.0%   Added value   1,801.8 1,030.1 617.6 3,334.8 2,144.5 1,006.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   63.5% 48.4% 33.7% 71.9% 58.5% 39.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   14.4% 8.2% 5.4% 24.3% 16.8% 4.4% 0.0% 0.0%   ROI %   15.2% 8.4% 5.6% 25.6% 17.7% 4.6% 0.0% 0.0%   ROE %   14.5% 8.1% 4.8% 27.0% 17.8% 3.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   77.9% 76.2% 68.3% 76.6% 83.6% 82.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   155.2% 372.1% 809.4% 135.4% 69.9% 425.5% 0.0% 0.0%   Gearing %   18.4% 23.3% 29.0% 19.9% 9.8% 16.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.6% 3.5% 3.5% 2.8% 5.0% 10.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.5 0.4 0.3 0.3 0.9 0.7 0.0 0.0   Current Ratio   0.5 0.4 0.3 0.3 0.9 0.7 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 936.7 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,701.1 -2,335.1 -4,885.2 -3,574.6 -468.1 -1,357.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   450 515 206 1,112 715 335 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   450 515 206 1,112 715 335 0 0   EBIT / employee   450 515 206 1,112 715 335 0 0   Net earnings / employee   513 640 271 1,796 1,406 288 0 0